Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: back pain

Cannabis for Pain Relief: An Area Ripe for Research

Vanessa Caceres  |  September 28, 2023

Medical cannabis may benefit patients experiencing pain, and rheumatologists should be able to discuss its potential risks and benefits with their patients. Here are insights from Dr. Mary Ann Fitzcharles on current research, patient use and more.

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:marijuanaPain Syndrome FocusRheum

Lost and found

A Look Back at the First Use of Cortisone in Rheumatoid Arthritis

Ruth Jessen Hickman, MD  |  January 17, 2023

In 1949, the first description of patients with rheumatoid arthritis (RA) given cortisone sent shockwaves through the medical community, quickly capturing the public imagination as well. The paradigm-shifting report paved the way for the use of cortisone and related drugs in RA and many other medical conditions.1 The following is a discussion of some of…

Filed under:ConditionsRheumatoid Arthritis Tagged with:cortisoneLost & Found

Elevated BMI Associated with Pain in Patients with Hand OA

Lara C. Pullen, PhD  |  November 8, 2022

Research from Gloersen et al. suggests the systemic effects of obesity, as measured by leptin, may play a role in the severity of pain experienced by patients with hand osteoarthritis.

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:BMIbody mass index (BMI)handhand osteoarthritishand painOsteoarthritisosteoarthritis (OA)

How to Help Patients with Chronic Pain

Samantha C. Shapiro, MD  |  June 18, 2022

Pain is more than nociception, and pain management is more than medication. Delia Chiaramonte, MD, provided insights into how rheumatologists can help their patients ease and manage chronic pain.

Filed under:ACR ConvergenceConditionsEducation & TrainingMeeting ReportsOther ACR meetingsPain Syndromes Tagged with:ACR Education ExchangeChronic painchronic pain patientsPainPain ManagementPain Syndrome FocusRheum

Some Cannabis Products May Ease Chronic Pain, But Side Effects Are a Concern

Reuters Staff  |  June 15, 2022

NEW YORK (Reuters Health)—Oral synthetic cannabis products that have a high tetrahydrocannabinol (THC) to cannabidiol (CBD) ratio, as well as extracted cannabis products with comparable THC-to-CBD ratios, may provide moderate, short-term improvements in chronic pain, a large systematic review of relevant research suggests.1 However, these products are also associated with higher risks for side effects,…

Filed under:ConditionsPain Syndromes Tagged with:cannabidiol (CBD)Chronic painPainPain Managementtetrahydrocannabinol (THC))

Rheum After 5: Dr. Umbreen Hasan, Painter

Linda Childers  |  May 12, 2022

A practicing rheumatologist for 20 years, Umbreen Hasan, MD, FACP, MBA, Coon Rapids, Minn., knows how challenging it can be to work through pain. Over the years, she has helped many patients learn how to manage chronic pain so they can continue to pursue the activities they love. Five years ago, after suffering a severe…

Filed under:ProfilesRheum After 5 Tagged with:Dr. Umbreen Hasan

Intra-Articular Steroid/Lidocaine Injection Improves Hip Arthritis Pain, Function

Reuters Staff  |  May 10, 2022

NEW YORK (Reuters Health)—A single injection into the hip of steroid and local anesthetic improved pain and function in patients with hip osteoarthritis in a randomized controlled trial, with most of the benefit seen early after treatment. Researchers at two community-based clinics in England assigned 199 volunteers to receive either an ultrasound guided intra-articular hip…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:corticosteroid injectionhiphip osteoarthritship painintra-articular corticosteroidsOsteoarthritisPainPain Management

Telehealth Exercise & Diet Programs Curb Pain & Boost Function in Knee OA

Marilynn Larkin  |  December 3, 2021

NEW YORK (Reuters Health)—In patients with knee osteoarthritis (OA), telehealth-delivered exercise and diet programs are superior to electronic health information for reducing pain and improving function, although the contribution of diet is modest, a randomized trial shows.1 “This research provides evidence from a large clinical trial to help tease out how much benefit dietary weight…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:DietExercise/physical therapykneeKnee Osteoarthritis (OA)knee paintelehealthtelemedicine

Oral CBD Fails to Relieve Pain from Hand OA & PsA

Reuters Staff  |  September 21, 2021

NEW YORK (Reuters Health)—Lower doses of cannabidiol (CBD) failed to provide any meaningful reduction in pain when added to other analgesic therapy in patients with hand osteoarthritis (OA) or psoriatic arthritis (PsA) in a randomized, placebo-controlled study from Denmark.1 Writing in the journal, Pain, Jonathan Vela, MD, and colleagues of Aalborg University note that CBD…

Filed under:AnalgesicsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:cannabidiol (CBD)hand osteoarthritishand painPainPsAPsoriatic Arthritis

Grit, Gratitude & Grace: Resilience Despite the Pain

Mary Beth Nierengarten  |  March 24, 2021

Clinicians can help their patients tap into personal resilience, and such characteristics as grit, gratitude and grace, to manage their chronic pain, says Afton L. Hassett, PsyD.

Filed under:ACR ConvergenceConditionsMeeting ReportsPain Syndromes Tagged with:ACR Convergence 2020Chronic paingratitudePain Management

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 162
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences